NYSTATIN, TRIAMCINOLONE ACETONIDE

NYSTATIN, TRIAMCINOLONE ACETONIDE was reported 109 times

NYSTATIN, TRIAMCINOLONE ACETONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDIASTINAL INFECTION 1 0.5000
1 VITAMIN C ABNORMAL 1 0.1111
2 CONTRACEPTION 1 0.0370
3 BRONCHIAL HYPERACTIVITY 1 0.0227
4 NUCLEATED RED CELLS 1 0.0089
5 GENITAL INJURY 1 0.0075
6 CSF CELL COUNT INCREASED 1 0.0068
7 ENTEROBACTER PNEUMONIA 1 0.0064
8 UROBILINOGEN URINE INCREASED 1 0.0061
9 BORDERLINE GLAUCOMA 1 0.0054
10 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
11 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
12 POLYCHROMASIA 1 0.0033
13 TRANSFERRIN SATURATION INCREASED 1 0.0029
14 VASCULAR INSUFFICIENCY 1 0.0026
15 URINARY CASTS 1 0.0026
16 ENDOMETRIAL HYPERTROPHY 1 0.0025
17 STICKY SKIN 1 0.0025
18 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
19 NITRITE URINE PRESENT 1 0.0023
20 POST THROMBOTIC SYNDROME 1 0.0022
21 TINEA CRURIS 1 0.0020
22 CSF TEST ABNORMAL 1 0.0020
23 POSTURING 1 0.0019
24 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
25 PRODUCT CLOSURE ISSUE 1 0.0018
26 PERFUME SENSITIVITY 1 0.0018
27 OPEN ANGLE GLAUCOMA 1 0.0016
28 URINARY SEDIMENT PRESENT 1 0.0016
29 VULVAL DISORDER 1 0.0015
30 PAINFUL ERECTION 1 0.0015
31 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
32 MONOCYTE PERCENTAGE INCREASED 1 0.0014
33 PRODUCT DESIGN ISSUE 1 0.0014
34 HAPTOGLOBIN DECREASED 1 0.0012
35 RETICULOCYTE COUNT INCREASED 1 0.0012
36 MEAN PLATELET VOLUME DECREASED 1 0.0012
37 RED BLOOD CELLS URINE POSITIVE 1 0.0010
38 ANTISOCIAL BEHAVIOUR 1 0.0010
39 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
40 STEROID WITHDRAWAL SYNDROME 1 0.0010
41 PRODUCT SELECTION ERROR 1 0.0009
42 CARBON DIOXIDE DECREASED 1 0.0009
43 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
44 MONOCYTE COUNT DECREASED 1 0.0008
45 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
46 OVARIAN CYST RUPTURED 1 0.0008
47 LIP EXFOLIATION 1 0.0008
48 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
49 VULVOVAGINAL CANDIDIASIS 1 0.0007
50 CULTURE URINE POSITIVE 1 0.0007
51 BACTERIAL VAGINOSIS 1 0.0006
52 BLOOD CHLORIDE INCREASED 1 0.0006
53 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
54 PNEUMONIA KLEBSIELLA 1 0.0005
55 BLOOD IRON INCREASED 1 0.0005
56 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
57 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
58 NEUROGENIC BLADDER 1 0.0005
59 MIDDLE EAR EFFUSION 1 0.0005
60 BACTERIAL TEST POSITIVE 1 0.0004
61 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
62 RADICULOPATHY 1 0.0004
63 APPLICATION SITE HAEMORRHAGE 1 0.0004
64 APPLICATION SITE PAIN 8 0.0004
65 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
66 PRODUCT CONTAINER ISSUE 3 0.0003
67 PARAPLEGIA 1 0.0003
68 HAEMOTHORAX 1 0.0003
69 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
70 URINE ANALYSIS ABNORMAL 1 0.0003
71 PENILE PAIN 1 0.0003
72 BLOOD CREATININE DECREASED 1 0.0003
73 PLANTAR FASCIITIS 1 0.0003
74 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
75 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
76 PRODUCT STORAGE ISSUE 1 0.0003
77 CERVIX CARCINOMA 1 0.0003
78 APPLICATION SITE DISCOLOURATION 1 0.0002
79 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
80 UTERINE HAEMORRHAGE 1 0.0002
81 ONYCHOMYCOSIS 1 0.0002
82 RHINITIS ALLERGIC 1 0.0002
83 VAGINAL INFECTION 1 0.0002
84 SKIN ABRASION 1 0.0002
85 VULVOVAGINAL PAIN 1 0.0002
86 PROTEIN URINE PRESENT 1 0.0002
87 VULVOVAGINAL PRURITUS 1 0.0002
88 BLOOD LACTIC ACID INCREASED 1 0.0002
89 SERUM FERRITIN INCREASED 1 0.0002
90 ANORECTAL DISCOMFORT 1 0.0002
91 CHEILITIS 1 0.0002
92 APPLICATION SITE PRURITUS 4 0.0002
93 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
94 PROTHROMBIN TIME PROLONGED 1 0.0002
95 APPLICATION SITE IRRITATION 2 0.0002
96 HAEMOGLOBIN ABNORMAL 1 0.0002
97 APPLICATION SITE VESICLES 1 0.0002
98 WRONG PRODUCT ADMINISTERED 1 0.0001
99 PRODUCT LABEL ISSUE 1 0.0001
100 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
101 BREAST TENDERNESS 1 0.0001
102 HAEMOLYSIS 1 0.0001
103 BLOOD ALBUMIN DECREASED 1 0.0001
104 DECUBITUS ULCER 1 0.0001
105 PYELONEPHRITIS 1 0.0001
106 APPLICATION SITE ERYTHEMA 3 0.0001
107 GROIN PAIN 1 0.0001
108 WRONG DRUG ADMINISTERED 1 0.0001
109 LOSS OF LIBIDO 1 0.0001
110 LIP DRY 1 0.0001
111 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
112 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
113 AFFECT LABILITY 1 0.0001
114 VITAMIN D DEFICIENCY 1 0.0001
115 KIDNEY INFECTION 2 0.0001
116 OVARIAN CYST 1 0.0001
117 VAGINAL DISCHARGE 1 0.0001
118 NEUTROPHIL COUNT INCREASED 1 0.0001
119 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
120 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
121 SKIN LACERATION 1 0.0001
122 PRODUCT DISPENSING ERROR 2 0.0001
123 GASTROINTESTINAL PAIN 1 0.0001
124 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
125 EXPIRED PRODUCT ADMINISTERED 3 0.0001
126 MITRAL VALVE INCOMPETENCE 1 0.0001
127 MYOCARDIAL ISCHAEMIA 1 0.0001
128 MUSCLE SPASTICITY 1 0.0001
129 DERMATITIS ALLERGIC 1 0.0001
130 ROTATOR CUFF SYNDROME 1 0.0001
131 PLATELET COUNT INCREASED 1 0.0001
132 INCORRECT PRODUCT STORAGE 1 0.0001
133 APPLICATION SITE RASH 1 0.0001
134 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
135 CARDIOMYOPATHY 1 0.0001
136 IMMUNODEFICIENCY 1 0.0001
137 OSTEOPENIA 1 0.0001
138 LYMPHOMA 1 0.0001
139 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
140 BLOOD POTASSIUM INCREASED 1 0.0001
141 FUNGAL INFECTION 2 0.0001
142 BLOOD UREA INCREASED 1 0.0001
143 BURNING SENSATION 4 0.0001
144 LYMPHOCYTE COUNT DECREASED 1 0.0001
145 HEAD DISCOMFORT 1 0.0001
146 TOOTHACHE 1 0.0001
147 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
148 BLOOD URINE PRESENT 1 0.0001
149 DRUG PRESCRIBING ERROR 1 0.0001
150 SKIN FISSURES 1 0.0001
151 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
152 HAEMATOCRIT DECREASED 1 0.0001
153 BLOOD PRESSURE ABNORMAL 1 0.0001
154 PRODUCT ADMINISTRATION ERROR 1 0.0000
155 DERMATITIS 1 0.0000
156 SKIN CANCER 1 0.0000
157 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
158 PRODUCT PRESCRIBING ISSUE 1 0.0000
159 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
160 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
161 CHROMATURIA 1 0.0000
162 SKIN IRRITATION 2 0.0000
163 BLOOD CHOLESTEROL INCREASED 2 0.0000
164 RASH ERYTHEMATOUS 2 0.0000
165 NEURALGIA 1 0.0000
166 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
167 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
168 MENSTRUATION IRREGULAR 1 0.0000
169 DRUG EFFECT DECREASED 2 0.0000
170 FREQUENT BOWEL MOVEMENTS 1 0.0000
171 BLOOD BILIRUBIN INCREASED 1 0.0000
172 LIMB INJURY 1 0.0000
173 WOUND 1 0.0000
174 PAIN IN JAW 1 0.0000
175 RED BLOOD CELL COUNT DECREASED 1 0.0000
176 EYE IRRITATION 2 0.0000
177 ACUTE MYOCARDIAL INFARCTION 1 0.0000
178 URINARY INCONTINENCE 1 0.0000
179 BLOOD POTASSIUM DECREASED 1 0.0000
180 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
181 CORONARY ARTERY DISEASE 1 0.0000
182 CYSTITIS 1 0.0000
183 SWELLING FACE 2 0.0000
184 SKIN DISORDER 1 0.0000
185 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
186 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
187 GASTRIC DISORDER 1 0.0000
188 DELIRIUM 1 0.0000
189 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
190 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
191 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
192 C-REACTIVE PROTEIN INCREASED 1 0.0000
193 DYSGEUSIA 2 0.0000
194 DYSARTHRIA 1 0.0000
195 JOINT SWELLING 3 0.0000
196 OSTEOPOROSIS 1 0.0000
197 CARDIO-RESPIRATORY ARREST 1 0.0000
198 SKIN EXFOLIATION 2 0.0000
199 URINARY TRACT INFECTION 4 0.0000
200 HYPOACUSIS 1 0.0000
201 VAGINAL HAEMORRHAGE 1 0.0000
202 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
203 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
204 PRODUCT QUALITY ISSUE 3 0.0000
205 NEPHROLITHIASIS 1 0.0000
206 HYPOKALAEMIA 1 0.0000
207 COGNITIVE DISORDER 1 0.0000
208 DISEASE RECURRENCE 1 0.0000
209 BLOOD GLUCOSE DECREASED 1 0.0000
210 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
211 PRURITUS 8 0.0000
212 CELLULITIS 1 0.0000
213 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
214 INFLAMMATION 1 0.0000
215 ECZEMA 1 0.0000
216 DERMATITIS ATOPIC 1 0.0000
217 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
218 HAEMATOCHEZIA 1 0.0000
219 ANAPHYLACTIC REACTION 1 0.0000
220 MEDICATION ERROR 1 0.0000
221 HYPONATRAEMIA 1 0.0000
222 EYE PAIN 1 0.0000
223 FLATULENCE 1 0.0000
224 DRUG INEFFECTIVE 23 0.0000
225 PRODUCT SUBSTITUTION ISSUE 1 0.0000
226 DYSPHONIA 1 0.0000
227 PLEURAL EFFUSION 1 0.0000
228 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
229 PRODUCT DOSE OMISSION 1 0.0000
230 DRY SKIN 2 0.0000
231 WEIGHT DECREASED 4 0.0000
232 THERAPY INTERRUPTED 1 0.0000
233 AGITATION 1 0.0000
234 PERIPHERAL SWELLING 2 0.0000
235 CARDIAC FAILURE CONGESTIVE 1 0.0000
236 ABDOMINAL DISCOMFORT 2 0.0000
237 RASH 5 0.0000
238 INSOMNIA 3 0.0000
239 NO ADVERSE EVENT 2 0.0000
240 MUSCLE SPASMS 2 0.0000
241 OROPHARYNGEAL PAIN 1 0.0000
242 CHEST PAIN 2 0.0000
243 BLOOD GLUCOSE INCREASED 2 0.0000
244 DYSPHAGIA 1 0.0000
245 MIGRAINE 1 0.0000
246 ATRIAL FIBRILLATION 1 0.0000
247 SYNCOPE 1 0.0000
248 CONDITION AGGRAVATED 3 0.0000
249 SINUSITIS 1 0.0000
250 ERYTHEMA 2 0.0000
251 ILLNESS 1 0.0000
252 HAEMORRHAGE 1 0.0000
253 INFLUENZA 1 0.0000
254 DEPRESSION 2 0.0000
255 CHILLS 1 0.0000
256 OEDEMA PERIPHERAL 1 0.0000
257 PAIN 5 0.0000
258 DIARRHOEA 5 0.0000
259 RENAL FAILURE 1 0.0000
260 VISION BLURRED 1 0.0000
261 INFECTION 1 0.0000
262 HYPOAESTHESIA 1 0.0000
263 BLOOD PRESSURE INCREASED 1 0.0000
264 VOMITING 3 0.0000
265 DRUG INTERACTION 1 0.0000
266 CONFUSIONAL STATE 1 0.0000
267 TREMOR 1 0.0000
268 CEREBROVASCULAR ACCIDENT 1 0.0000
269 OFF LABEL USE 5 0.0000
270 COVID-19 1 0.0000
271 ANAEMIA 1 0.0000
272 GAIT DISTURBANCE 1 0.0000
273 FATIGUE 4 0.0000
274 NAUSEA 4 0.0000
275 HEADACHE 3 0.0000
276 CONSTIPATION 1 0.0000
277 MALAISE 2 0.0000
278 WEIGHT INCREASED 1 0.0000
279 INCORRECT DOSE ADMINISTERED 1 0.0000
280 BACK PAIN 1 0.0000
281 ABDOMINAL PAIN 1 0.0000
282 FEELING ABNORMAL 1 0.0000
283 DIZZINESS 2 0.0000
284 PNEUMONIA 1 0.0000
285 PYREXIA 1 0.0000
286 ASTHENIA 1 0.0000
287 DYSPNOEA 1 0.0000